Surfactant barrier lining peritoneal mesothelium: Lubricant and release agent

Peritoneal Dialysis International

Volumn 18, Issue 2, 1998, Pages 157-165

  Hills, Brian A ^a   Burke, John R ^b   Thomas, Kristen ^a  

^a MATER CHILDREN S HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Peritoneal lubricity; Peritoneal surfactant; Surfactant; Tight junctions; Tissue release; Ubiquitous barrier; Ultrafiltration

Indexed keywords

BILE SALT; LUBRICATING AGENT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SURFACTANT;

ANIMAL TISSUE; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DOG; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; MESOTHELIUM; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; SPECTROSCOPY; ULTRASOUND;

EID: 0031894090     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800203     Document Type: Article

References (52)

1. White R, Korthuis R, Granger DN. The peritoneal microcirculation in peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer; 1994:45-68.
2. Agostoni E. Mechanics of the pleural space. Physiol Rev 1972; 52:57-128.
3. Hills BA, Butler BD, Barrow RE. Boundary lubrication imparted by pleural surfactants and their identification. J Appl Physiol 1982; 53:463-9.
4. Hardy, Sir WB. Collected papers. Cambridge: Cambridge University Press, 1935.
5. Adamson AW. Physical chemistry of surfaces. 2nd ed. New York: Wiley, 1967.
6. Hills BA. The biology of surfactant. Cambridge: Cambridge University Press, 1988.
7. Hills BA, Butler BD. Surfactants identified on the pericardium and their ability to impart boundary lubrication. Ann Biomed Eng 1985; 13:573-86.
8. Hills BA. Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant. J Appl Physiol 1992; 73:1034-9.
9. Campbell ME. A review of solid lubrication technology. New York: Society of Automotive Engineers, 1971:1-6.
10. Grahame GR, Torchia MG, Dankewich KA, Ferguson IA. Surface-active material in peritoneal effluent on CAPD patients. Perit Dial Bull 1985; 5:109-11.
11. Dobbie JW. Surfactant protein A and lamellar bodies: a homologous secretory function of peritoneum, synovium and lung. Perit Dial Int 1996; 16:574-81.
12. Hills BA. Lubrication of visceral movement and gastric motility by peritoneal surfactant. J Gastroenterol Hepatol 1996; 11:797-803.
13. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph ED, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer, 1994: 69-113.
14. Dobbie JW. Ultrastructure and pathology of the peritoneum in peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer, 1994:17-44.
15. Hawgood S, Clements JA. Pulmonary surfactant and its proteins. J Clin Invest 1990; 86:1-66.
16. Hills BA. How does surfactant really function? Pediatr Pulmonol 1995; 20:328-30.
17. Ueda S, Ishii N, Matsumoto S, Hayashi K, Okayasu M. Ultrastructural studies on surface lining layer of the lungs. Part II. J Jpn Med Soc Biol Interface 1983; 14:24-46.
18. Ueda S, Kawamura K, Ishii N, Matsumoto S, Hayashi K, Okayasu M, et al. Ultrastructural studies on surface lining layer of the lungs. Part IV. Resected human lung. J Jpn Med Soc Biol Interface 1985; 16:34-60.
19. Hills BA. A hydrophobic oligolamellar lining to surfaces in various tissues: a possible ubiquitous barrier. Med Sci Res 1992; 20:543-50.
20. Mason RJ, Williams MC, Greenleaf RD, Clements JA. Isolation and properties of type II alveolar cells from rat lung. Am Rev Respir Dis 1977; 115:1015-26.
21. Sabatini DD, Bensch K, Barnett RJ. Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. J Cell Biol 1963; 17:19-57.
22. Schrijvers AHGJ, Frederik PM, Stuart MCA, Burger KNJ, Heijnen W, Van Der Vusse GJ, Reneman RS. Formation of multilamellar vesicles by addition of tannic acid to phosphatidylcholine-containing small unilamellar vesicles. J Histochem Cytochem 1989; 37:1635-43.
23. Hills BA, Butler BD, Lichtenberger LM. Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 1983; 244:G561-8.
24. Untersee P, Gil J, Weibel ER. Visualization of extracellular lining layer of lung alveoli by freeze-etching. Respir Physiol 1971; 13:171-85.
25. Nolph KD, Miller F, Rubin J, Popovich R. New directions in peritoneal dialysis concepts and applications. Kidney Int 1980; 18:5111-16.
26. Dulaney JT, Hatch FE. Peritoneal dialysis and loss of proteins: a review. Kidney Int 1984; 26:253-62.
27. Ar'RajabA, Snoj M, LarssonK, Bengmark S. Exogenous phospholipid reduces postoperative peritoneal adhesions in rats. Eur J Surg 1995; 161:341-4.
28. Mion CM, Boen ST. Analysis of factors responsible for the formation of adhesions during chronic peritoneal dialysis. Am J Med Sci 1965; 250:675-9.
29. Absolom DR, Zingg W, Neumann AW. Measurement of contact angles on biological and other highly hydrated surfaces. J Colloid Interface Sci 1986; 112:599-601.
30. Black RB, Hole AR, Rhodes J. Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology 1971; 61;178-84.
31. Ueda S, Kawamura K, Ishii N, Matsumoto S, Hayashi K, Okayasu M, et al. Morphological studies on lung surfactant. J Jpn Med Soc Biol Interface 1985; 16:81-109.
32. Bangham AD, Home RW. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 1964; 8:660-8.
33. Rouser G, Siakotos AN, Fleischer S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966; 1:85-6.
34. American Society for Testing Materials. Standard test method for yield strength of preformed sealing tapes. Designation C908-79. Philadelphia: ASTM, 1979.
35. Hills BA. Analysis of eustachian surfactant and its function as a release agent. Arch Otolaryngol 1984; 110:3-9.
36. Radin EL, Paul IL, Swann DA, Schottstaedt ES. Lubrication of synovial membrane. Ann Rheum Dis 1971; 30:322-5.
37. Hills BA, Butler BD. Surfactants identified in synovial fluid and their ability to act as boundary lubricants. Ann Rheum Dis 1984; 48:51-7.
38. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
39. Hills BA. Arrest of metastatic cells. Agents promoting and inhibiting non-specific adhesion by fibronectin. Anticancer Res 1985; 5:287-92.
40. Hills BA. Remarkable anti-wear properties of joint surfactant. Ann Biomed Eng 1995; 23:112-15.
41. Hills BA. Oligolamellar nature of the articular surface. J Rheumatol 1990; 17:349-56.
42. Leypoldt JTK, Mistry CD. Ultrafiltration in peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer, 1994:135-60.
43. Torres IJ, Litterst CI, Guarino AM. Transport of model compounds across the peritoneal membrane in the rat. Pharmacology 1978; 17:330-40.
44. Hirszel P, Lamiere N, Bogaert M. Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum. In: Gokal R, Nolph KD, eds, The textbook of peritoneal dialysis. Dordrecht: Kluwer, 1994:161-232.
45. Penzotti SC, Mattocks AM. Acceleration of peritoneal dialysis by surface-active agents. J Pharm Sci 1968; 57:1192-5.
46. Breborowicz A, Sombolos K, Rodela H, Ogilvie R, Bergman J, Oreopoulos DG. Mechanism of phosphatidylcholine action during peritoneal dialysis. Perit Dial Bull 1987; 7:6-9.
47. Rohsenow WM, Choi HY. Heat mass and momentum transfer. Englewood Cliffs, NJ: Prentice Hall, 1961.
48. Hills BA, Hughes GM. A dimensional analysis of oxygen transfer in the fish gill. Respir Physiol 1970; 9:126-40.
49. Zirgler C, Torchia M, Grahame G, Ferguson I. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1989; 9:47-9.
50. Beavis J, Harwood JL, Coles GA, Williams JD. Intraperitoneal phosphatidylcholine levels in patients on continuous ambulatory peritoneal dialysis do not correlate with adequacy of ultrafiltration. J Am Soc Nephrol 1993; 3:1954-60.
51. Krack G, Viglino G, Cavalli PL, Gandolfo C, Magliano G, Cantaluppi A, et al. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12:359-64.
52. Breborowicz A, Wierczorowska K, Witowski J, Martis L, Oreopoulos DG. Phosphatidylcholine and chondroitin sulphate in peritoneal dialysis fluids to preserve membrane function. Perit Dial Int 1994; 14(Suppl 3): S139-42.